the efficacy of cefotaxime was comparable to that of appg-probenecid in the treatment of uncomplicated genital or rectal infection due to beta-lactamase-negative n. gonorrhoeae , and cefotaxime appears to be highly effective for the treatment of urethral infection due to beta-lactamase-positive n. gonorrhoeae .
C0033209
probenecid
C0018081
gonorrhoeae